产品说明
应用
Tetrabenazine has been used for dopamine uptake assays in mouse brain cells1. Tetrabenazine has also been used for non-specific binding assays in postnuclear supernatants derived from PC-12 and CV-1 cells2.
包装
10, 50 mg in glass bottle
生化/生理作用
Tetrabenazine is a reversible type 2 vesicular monoamine transporter (VMAT) inhibitor. It depletes dopamine stores.
特点和优势
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
制备说明
Tetrabenazine is soluble in DMSO at a concentration that is greater than 10 mg/ml and is insoluble in water.
基本信息
经验(实验)分子式 | C19H27NO3 |
分子量 | 317.42 |
Beilstein | 40090 |
EC 号 | 200-383-6 |
MDL编号 | MFCD08461052 |
PubChem化学物质编号 | 329826731 |
NACRES | NA.77 |
产品性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | solid |
溶解性 | DMSO: >10 mg/mL H2O: insoluble |
创始人 | Roche |
储存温度 | 2-8℃ |
SMILES string | COc1cc2CCN3C[C@@H](CC(C)C)C(=O)CC3c2cc1OC |
InChI | 1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1 |
InChI key | MKJIEFSOBYUXJB-GDBMZVCRSA-N |
安全信息
象形图 | |
警示用语: | Warning |
危险声明 | H302 |
预防措施声明 | P264 - P270 - P301 + P312 - P501 |
危险分类 | Acute Tox. 4 Oral |
储存分类代码 | 13 - Non Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
Sigma-Aldrich